Robert Chen is currently the VP and Head of Hematology Clinical Development at AstraZeneca, a position held since 2024. Previously, they served as the Global Head of Lymphoma Clinical Development and Strategy at AstraZeneca from 2021 to 2025 and were the Executive Director of Clinical Development at Autolus Ltd. from 2019 to 2021. With a background in academia, Robert worked as an Associate Professor of Medicine and Associate Director of the Toni Stephenson Lymphoma Center at City of Hope from 2008 to 2018. They earned their Doctor of Medicine degree from the Feinberg School of Medicine at Northwestern University and a Bachelor of Arts in Cell/Cellular and Molecular Biology from Northwestern University.
This person is not in any teams
This person is not in any offices